The ophthalmologic drug developer has gone public three years after being founded by WuXi AppTec-backed 6 Dimensions Capital.

University of Toronto and McMaster University-founded glioblastoma Car T-cell therapy developer Empirca Therapeutics has been acquired by Century Therapeutics.

The banking software provider's shares have nearly tripled following an offering in which it floated well above its range.

The online employee and further education provider has listed on TSE’s Mothers Market, allowing Tokyo Institute of Technology to exit.

The online retail software provider, which has raised $219m in venture funding from investors including Telstra, Softbank and American Express, set a $100m target.

The Baidu and SoftBank-backed on-demand staff provider floated in the middle of its range in a US offering and its market cap currently stands at about $600m.

The GSK, Amgen and Novo-backed cancer drug developer went public in an upsized offering priced above its range.

Meituan Dianping is the largest investor in the China-based smart electric vehicle producer, which has set a $100m placeholder target for its initial public offering.

Primary care network Oak Street Health has filed for a $100m offering on the New York Stock Exchange that will give Humana an exit.

The SingTel, WarnerMedia and Sony-backed streaming service filed for liquidation in March and has reportedly agreed to let Coupang buy its assets.